Pharmacogenomics and Implications for Nursing Practice

被引:17
作者
Cheek, Dennis J. [1 ,2 ]
Bashore, Lisa [1 ]
Brazeau, Dan Alan [3 ,4 ]
机构
[1] Texas Christian Univ, Harris Coll Nursing & Hlth Sci, Ft Worth, TX 76129 USA
[2] Texas Christian Univ, Sch Nurse Anesthesia, Ft Worth, TX 76129 USA
[3] Univ New England, Genom Analyt & Prote, Portland, ME USA
[4] Univ New England, Coll Pharm, Portland, ME USA
关键词
Advanced practice nursing; genomics; pharmacogenetic; pharmacogenomics; nursing; DRUG-METABOLIZING-ENZYMES; IMPLEMENTATION CONSORTIUM; BREAST-CANCER; POLYMORPHISMS; TRANSPORTERS; VARIABILITY; RESISTANCE; MUTATIONS; GENOMICS; CYP2C9;
D O I
10.1111/jnu.12168
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Purpose This article aims to introduce the nurse to pharmacogenomics and its implications for clinical practice with regard to drug therapy. Organizing Constructs Pharmacogenomics is discussed with regard to the basic tenets, relationships to common health conditions, education and practice resources, and implications for nursing practice. Methods Peer-reviewed literature, websites, and expert professional guidelines were reviewed with relation to pharmacogenomics and nursing practice. Findings The genetic-genomic literature has grown significantly since the completion of the Human Genome Project in 2003. This information is now being translated into practice with regard to the patient's genetic profile and the impact on drug therapy, which is pharmacogenomics. Conclusions The utilization of the patient genetic-genomic profile is beginning to have an impact on patient drug therapy in clinical practice.
引用
收藏
页码:496 / 504
页数:9
相关论文
共 43 条
[1]  
Agency for Healthcare Research and Quality, 2015, GLOSS TERMS
[2]   Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications [J].
Aithal, GP ;
Day, CP ;
Kesteven, PJL ;
Daly, AK .
LANCET, 1999, 353 (9154) :717-719
[3]   McKusick's Online Mendelian Inheritance in Man (OMIM®) [J].
Amberger, Joanna ;
Bocchini, Carol A. ;
Scott, Alan F. ;
Hamosh, Ada .
NUCLEIC ACIDS RESEARCH, 2009, 37 :D793-D796
[4]  
[Anonymous], 1959, ERGEB INN MED KINDER
[5]  
[Anonymous], 2015, TABL PHARM BIOM DRUG
[6]  
Begg EJ, 2012, PHARMACOGENOMICS, V13, P83, DOI [10.2217/PGS.11.134, 10.2217/pgs.11.134]
[7]   Personalized Medicine, Genomics, and Pharmacogenomics: A Primer for Nurses [J].
Blix, Andrew .
CLINICAL JOURNAL OF ONCOLOGY NURSING, 2014, 18 (04) :437-441
[8]  
Centers for Medicare & Medicaid Services, 2014, MED COV DATABASEPOTE
[9]   Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy [J].
Cheok, MH ;
Evans, WE .
NATURE REVIEWS CANCER, 2006, 6 (02) :117-129
[10]   A New Initiative on Precision Medicine [J].
Collins, Francis S. ;
Varmus, Harold .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (09) :793-795